Literature DB >> 7945249

Cloning and characterization of the human osteopontin gene and its promoter.

N Hijiya1, M Setoguchi, K Matsuura, Y Higuchi, S Akizuki, S Yamamoto.   

Abstract

We isolated the human osteopontin (hOP) gene and the 5' upstream region, and analysed its exon-intron structure and potential regulatory sequences of the promoter region in comparison with those of the mouse and porcine gene. The coding sequence is split into 7 exons which are similar to those of the mouse gene, although the hOP gene is longer than the mouse gene. The difference in length is mainly due to variations in intron 3, which is approximately 2.7-fold longer than that of the mouse OP gene. The 5' upstream region of the hOP, which is highly conserved up to nucleotide -250, contains a number of potential cis regulatory consensus sequences. A series of sequentially 5'-deleted chimeric clones was tested for the ability to stimulate chloramphenicol acetyltransferase (CAT). Initial CAT analysis demonstrated that nucleotides at positions -474 to -270, -124 to -80, and -55 to -39 contained cis-acting enhancing sequences in a human monocyte cell line, SCC-3, although the -124 to -80 region was much more active than other regions. Deletion of the sequences between -474 and -270 localized this cis region to the sequence at positions -439 to -410, whereas the deletion between -124 to -80 localized the regions to -124 to -115, and -94 to -80. Gel-shift analysis using as probes synthesized double-stranded DNA corresponding to the 10 and 15 bp region at positions -124 to -115 and -94 to -80 respectively revealed that each probe formed a major band complexed with nuclear proteins prepared from SCC-3 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945249      PMCID: PMC1137584          DOI: 10.1042/bj3030255

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Nucleotide sequence of cDNA for mouse osteopontin-like protein.

Authors:  Y Miyazaki; M Setoguchi; S Yoshida; Y Higuchi; S Akizuki; S Yamamoto
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

2.  Mechanism of fibroblast attachment to bone extracellular matrix: role of a 44 kilodalton bone phosphoprotein.

Authors:  M J Somerman; C W Prince; J J Sauk; R A Foster; W T Butler
Journal:  J Bone Miner Res       Date:  1987-06       Impact factor: 6.741

3.  44-kDal bone phosphoprotein (osteopontin) antigenicity at ectopic sites in newborn rats: kidney and nervous tissues.

Authors:  M P Mark; C W Prince; S Gay; R L Austin; W T Butler
Journal:  Cell Tissue Res       Date:  1988-01       Impact factor: 5.249

4.  Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis.

Authors:  A M Craig; J H Smith; D T Denhardt
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

5.  Enhancement of c-fos expression is associated with activated macrophages.

Authors:  Y Higuchi; M Setoguchi; S Yoshida; S Akizuki; S Yamamoto
Journal:  Oncogene       Date:  1988-05       Impact factor: 9.867

6.  Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation.

Authors:  D R Senger; C A Perruzzi; C F Gracey; A Papadopoulos; D G Tenen
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

7.  Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor.

Authors:  M Noda; K Yoon; C W Prince; W T Butler; G A Rodan
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

8.  Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities.

Authors:  J H Smith; D T Denhardt
Journal:  J Cell Biochem       Date:  1987-05       Impact factor: 4.429

9.  Tissue specificity and developmental expression of rat osteopontin.

Authors:  K Yoon; R Buenaga; G A Rodan
Journal:  Biochem Biophys Res Commun       Date:  1987-11-13       Impact factor: 3.575

10.  Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone.

Authors:  M Noda; G A Rodan
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  26 in total

1.  Pre- and post-translational regulation of osteopontin in cancer.

Authors:  Pieter H Anborgh; Jennifer C Mutrie; Alan B Tuck; Ann F Chambers
Journal:  J Cell Commun Signal       Date:  2011-04-26       Impact factor: 5.782

Review 2.  CD44 and the adhesion of neoplastic cells.

Authors:  Z Rudzki; S Jothy
Journal:  Mol Pathol       Date:  1997-04

Review 3.  Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.

Authors:  A O'Regan; J S Berman
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

4.  Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection.

Authors:  G J Nau; G L Chupp; J F Emile; E Jouanguy; J S Berman; J L Casanova; R A Young
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

5.  Osteopontin is overexpressed in colorectal carcinoma and is correlated with P53 by immunohistochemistry.

Authors:  Jing Li; Guang-Zhi Yang; Zi-Man Zhu; Zhi-Yong Zhou; Lin Li
Journal:  Exp Ther Med       Date:  2012-01-30       Impact factor: 2.447

6.  Osteopontin regulates ubiquitin-dependent degradation of Stat1 in murine mammary epithelial tumor cells.

Authors:  Chengjiang Gao; Zhiyong Mi; Hongtao Guo; Paul C Kuo
Journal:  Neoplasia       Date:  2007-09       Impact factor: 5.715

7.  Elevation of osteopontin levels in brain tumor cells reduces burden and promotes survival through the inhibition of cell dispersal.

Authors:  Stephen M Selkirk; Jay Morrow; Tara A Barone; Alan Hoffer; Jeffrey Lock; Anne DeChant; Saisho Mangla; Robert J Plunkett; Robert H Miller
Journal:  J Neurooncol       Date:  2007-10-11       Impact factor: 4.130

Review 8.  Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition.

Authors:  Anne George; Arthur Veis
Journal:  Chem Rev       Date:  2008-10-03       Impact factor: 60.622

9.  Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells.

Authors:  Yoji Takami; Michael B Russell; Chengjiang Gao; Zhiyong Mi; Hongtao Guo; Christopher R Mantyh; Paul C Kuo
Journal:  Surgery       Date:  2007-08       Impact factor: 3.982

10.  Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer.

Authors:  Zhiyong Mi; Hongtao Guo; Paul C Kuo
Journal:  BMC Res Notes       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.